A Phase III Prospective Randomized Trial Of Dose-Escalated Radiotherapy With Or Without Short-Term Androgen Deprivation Therapy For Patients With Intermediate-Risk Prostate Cancer
RATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill
tumor cells and shrink tumors. Androgens can cause the growth of prostate cancer cells.
Androgen-deprivation therapy may lessen the amount of androgens made by the body. It is not
yet known whether radiation therapy is more effective with or without androgen-deprivation
therapy in treating patients with prostate cancer.
PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it
works compared with radiation therapy given together with androgen-deprivation therapy in
treating patients with prostate cancer.
Keene,Southwestern Vermont,St. Johnsbury, VT
View more details from ClinicalTrials.gov.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.